What amount sold does Piraeus Medical, Inc. report in Form D filings?

The latest linked filings report $21.1M sold across 10 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Piraeus Medical, Inc.'s most recent SEC filing?

Piraeus Medical, Inc.'s most recent Form D filing was on 2026-10-07.

How many investors does Piraeus Medical, Inc. have?

The most recent Form D filing lists 25 investor(s).

What type of securities does Piraeus Medical, Inc. offer?

Piraeus Medical, Inc.'s SEC Form D filings indicate equity offerings.

Piraeus Medical, Inc.

CIK: 0001933134·Other Health Care·ROCHESTER, MN·Corporation

Reported Sold

$21,053,309

Total Filings

Identified Offerings

Last Filed

Oct 7, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Health Care industry

SEC EDGAR

Offering filing timeline

Oct 7, 2026Form D/A — Amendment

Reported sold: $10,525,100 · Target: $12,025,100

Rule 506(b)·25 investors

Changed: Reported amount sold, Offering target, Reported investors

Apr 2, 2026Form D — New notice

Reported sold: $3,575,100 · Target: $10,525,100

Rule 506(b)·11 investors

Nov 5, 2025Form D — New notice

Reported sold: $662,600 · Target: $2,200,000

Rule 506(b)·4 investors

Sep 22, 2025Form D — New notice

Reported sold: $300,000 · Target: $300,000

Rule 506(b)·1 investor

Feb 19, 2025Form D — New notice

Reported sold: $2,000,001 · Target: $2,000,001

Rule 506(b)·65 investors

Jul 23, 2024Form D — New notice

Reported sold: $6,000,000 · Target: $6,000,000

Rule 506(b)·79 investors

Apr 4, 2024Form D/A — Amendment

Reported sold: $450,000 · Target: $3,500,000

Rule 506(b)·5 investors

Changed: Offering target

Aug 9, 2023Form D — New notice

Reported sold: $3,108 · Target: $3,108

Rule 506(b)·2 investors

Jul 3, 2023Form D — New notice

Reported sold: $450,000 · Target: $2,600,000

Rule 506(b)·5 investors

Dec 9, 2022Form D — New notice

Reported sold: $150,000 · Target: $3,500,000

Rule 506(b)·2 investors

Jun 16, 2022Form D — New notice

Reported sold: $900,000 · Target: Indefinite

Rule 506(b)·13 investors

Jun 9, 2022Form D — New notice

Reported sold: $62,500 · Target: $62,500

Rule 506(b)·2 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

17%

Latest reported sold across 10 identified offerings

$21,053,309

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Jared Hutar

Related Person

Appears on 6 filings

Kevin Kallmes

Related Person

Appears on 6 filings

Keith Kallmes

Related Person

Appears on 6 filings

Ryan Egeland

Related Person

Appears on 6 filings

Jared Hutar

Related Person

Appears on 6 filings

Keith Kallmes

Related Person

Appears on 6 filings

Kevin Kallmes

Related Person

Appears on 5 filings

Martin Omid Akhavan

Related Person

Appears on 5 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Oct 7, 2026	Amendment	$12,025,100	$10,525,100	25
Apr 2, 2026	New	$10,525,100	$3,575,100	11
Nov 5, 2025	New	$2,200,000	$662,600	4
Sep 22, 2025	New	$300,000	$300,000	1
Feb 19, 2025	New	$2,000,001	$2,000,001	65
Jul 23, 2024	New	$6,000,000	$6,000,000	79
Apr 4, 2024	Amendment	$3,500,000	$450,000	5
Aug 9, 2023	New	$3,108	$3,108	2
Jul 3, 2023	New	$2,600,000	$450,000	5
Dec 9, 2022	New	$3,500,000	$150,000	2
Jun 16, 2022	New	Indefinite	$900,000	13
Jun 9, 2022	New	$62,500	$62,500	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

AGITATED SOLUTIONS, INC.

Other Health Care

Offering target: $13,810,913

Filed Oct 20, 2026